CB2 Insights Announces Record Annual Revenue of $13.4 million for FY 2019 Sequential Growth of 25%

NEXT STORY
BeiGene Announces Acceptance of a Supplemental New Drug Application for Tislelizumab in Combination with Chemotherapy in First-Line Advanced Non-Squamous Non-Small Cell Lung Cancer in China
PREV STORY
PRA Health Sciences prête à satisfaire les exigences du RACE Act pour l’oncologie pédiatrique
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

mRNA Vaccines Market Report 2021-2031

author_avatar
NASDAQ Market News

The global in-vitro diagnostics market is expected to reach US$ 90,656.80 million by 2027 from US$ 63,746.63 million in 2019

author_avatar
NASDAQ Market News

Treos Bio Announces Activation of U.S. Clinical Trial Site for Phase 1 Study of PolyPEPI™ Precision Cancer Vaccine for Patients with Metastatic Colorectal Cancer

author_avatar
NASDAQ Market News